Author

Yong‐Qiang Deng

Academy of Military Medical SciencesORCID 0000-0002-2306-1039Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Cheng‐Feng QiniD· 2 shared Bowen ZhangiD· 1 shared Guangqian Pei· 1 shared Hang FaniD· 1 shared Hangyu ZhouiD· 1 shared Hui John ZhaoiD· 1 shared Jie ZhuiD· 1 shared Nana ZhangiD· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Cheng‐Feng QinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyJournal of Medical VirologyPeer-reviewedDec 1, 2023

Competitive fitness and homologous recombination of SARS-CoV-2 variants of concern

Qi Chen, Si Qin, Hangyu Zhou…·Cheng‐Feng Qin

This study examines the competitive fitness and homologous recombination of SARS-CoV-2 variants in vitro, showing cell-specific fitness differences and recombination hotspots.

3 citations

humanexperimental assay

𝕏 PostBluesky

Systems BiologybioRxivPreprintMay 2, 2020

An artificial intelligence system reveals liquiritin inhibits SARS-CoV-2 by mimicking type I interferon

Jie Zhu, Yong‐Qiang Deng, Xin Wang…·Zhengwei Xie

The paper identifies liquiritin as an antiviral compound that inhibits SARS-CoV-2 by mimicking type I interferon, showing efficacy in cell cultures and low toxicity in mice.

26 citations

mousehuman

𝕏 PostBluesky